(1) Background: COVID-19 was responsible for the latest pandemic, shaking and resha**
healthcare systems worldwide. Its late clinical manifestations make it linger in medical …

Among the various comorbidities potentially worsening the clinical outcome in patients
hospitalized for the acute respiratory syndrome coronavirus-2 (SARS-CoV-2), hypertension …

Cardiometabolic diseases like hypertension, type 2 diabetes mellitus, atherosclerosis, and
obesity have been associated with changes in the gut microbiota structure, or dysbiosis. The …

SARS-CoV-2 infects type II pneumocytes and disrupts redox homeostasis by overproducing
reactive oxygen species (ROS). N-acetyl cysteine (NAC) is a precursor of the synthesis of …

Background: The COVID-19 pandemic has brought significant attention to the role of dietary
supplements, particularly Vitamin D, in enhancing immunity and possibly mitigating the …

Remdesivir is the first FDA-approved drug for treating severe SARS-CoV-2 infection and
targets RNA-dependent RNA polymerase (RdRp) that is required for viral replication. To …

This narrative review examines the multifaceted realm of postoperative infections in
gynaecology, addressing their significance, types, risk factors, prevention, management, and …

COVID-19 is an independent risk factor for pulmonary embolism (PE). Little is known about
alteplase therapy in this patient group. A retrospective study analyzed 74 patients with PE …

Lifeways of worldwide people have changed dramatically amid the coronavirus disease
2019 (COVID-19) pandemic, and public health is at stake currently. In the early stage of …

Excessive inflammatory response has been implicated in severe respiratory forms of
coronavirus disease 2019 (COVID-19). Trace elements such as zinc, selenium, and copper …